ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL

Compare ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE (Beta-2 Agonist Bronchodilator) and TIOTROPIUM BROMIDE AND OLODATEROL (Beta-2 Agonist Bronchodilator) — clinical data, side effects, and patient experiences.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action DUAKLIR PRESSAIR DUAKLIR PRESSAIR contains two bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formo...

Approved for

5.4 )] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic

and formoterol fumarate

5.4 )

Respiratory (inhalation)Tablet

TIOTROPIUM BROMIDE AND OLODATEROL

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action STIOLTO RESPIMAT STIOLTO RESPIMAT contains both tiotropium and olodaterol. The properties described below for the individual components apply to STIOLTO RE...

Approved for

1 INDICATIONS AND USAGE STIOLTO RESPIMAT is a combination of tiotropium bromide

an anticholinergic and olodaterol

a long-acting beta 2 -adrenergic agonist (LABA) indicated for the long-term

once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)

Respiratory (inhalation)Tablet

Quick Comparison

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATETIOTROPIUM BROMIDE AND OLODATEROL

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

Shortness of Breath

>10%

Cough

1-10%

Drug Not Working

0.1-1%

General Unwellness

0.1-1%

TIOTROPIUM BROMIDE AND OLODATEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

0.1-1%

General Unwellness

0.1-1%

Nausea

0.1-1%

Headache

0.1-1%

Falls

0.1-1%

FDA Warnings

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

5 WARNINGS AND PRECAUTIONS • Asthma-related death: Long-acting beta 2 -adrenergic agonists as monotherapy (without an inhaled corticosteroid) for asthma increase the risk of serious asthma-related events
2 ) • Do not use in combination with an additional medicine containing a LABA because of risk of overdose
1 Serious Asthma-Related Events-Hospitalizations, Intubations, Death • The safety and efficacy of DUAKLIR PRESSAIR in patients with asthma have not been established
• Use of LABA as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

TIOTROPIUM BROMIDE AND OLODATEROL

5 WARNINGS AND PRECAUTIONS LABA as monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
Excessive use of STIOLTO RESPIMAT, or use in conjunction with other medications containing LABA can result in clinically significant cardiovascular effects and may be fatal
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and efficacy of STIOLTO RESPIMAT in patients with asthma have not been established
Use of long-acting beta 2 -adrenergic agonists (LABA) as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL: What You Should Know

Key Differences

Both ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE and TIOTROPIUM BROMIDE AND OLODATEROL belong to the Beta-2 Agonist Bronchodilator class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE carries 4 FDA warnings. TIOTROPIUM BROMIDE AND OLODATEROL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL→ALBUTEROL vs TIOTROPIUM BROMIDE AND OLODATEROL→LEVALBUTEROL HYDROCHLORIDE vs TIOTROPIUM BROMIDE AND OLODATEROL→FORMOTEROL FUMARATE DIHYDRATE vs TIOTROPIUM BROMIDE AND OLODATEROL→FLUTICASONE PROPIONATE AND SALMETEROL vs TIOTROPIUM BROMIDE AND OLODATEROL→ALBUTEROL SULFATE vs TIOTROPIUM BROMIDE AND OLODATEROL→

Loading comparison data...

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action DUAKLIR PRESSAIR DUAKLIR PRESSAIR contains two bronchodilators: aclidinium a long-acting muscarinic antagonist (also known as an anticholinergic) and formo...

Approved for

5.4 )] . DUAKLIR PRESSAIR is a combination of aclidinium bromide an anticholinergic

and formoterol fumarate

5.4 )

Respiratory (inhalation)Tablet

TIOTROPIUM BROMIDE AND OLODATEROL

· Beta-2 Agonist Bronchodilator

How it works

12.1 Mechanism of Action STIOLTO RESPIMAT STIOLTO RESPIMAT contains both tiotropium and olodaterol. The properties described below for the individual components apply to STIOLTO RE...

Approved for

1 INDICATIONS AND USAGE STIOLTO RESPIMAT is a combination of tiotropium bromide

an anticholinergic and olodaterol

a long-acting beta 2 -adrenergic agonist (LABA) indicated for the long-term

once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (COPD)

Respiratory (inhalation)Tablet

Quick Comparison

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATETIOTROPIUM BROMIDE AND OLODATEROL

Drug Class

Beta-2 Agonist Bronchodilator

Route

Respiratory (inhalation)

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

Shortness of Breath

>10%

Cough

1-10%

Drug Not Working

0.1-1%

General Unwellness

0.1-1%

TIOTROPIUM BROMIDE AND OLODATEROL

Shortness of Breath

>10%

Drug Not Working

1-10%

Cough

1-10%

Fatigue

0.1-1%

General Unwellness

0.1-1%

Nausea

0.1-1%

Headache

0.1-1%

Falls

0.1-1%

FDA Warnings

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE

5 WARNINGS AND PRECAUTIONS • Asthma-related death: Long-acting beta 2 -adrenergic agonists as monotherapy (without an inhaled corticosteroid) for asthma increase the risk of serious asthma-related events
2 ) • Do not use in combination with an additional medicine containing a LABA because of risk of overdose
1 Serious Asthma-Related Events-Hospitalizations, Intubations, Death • The safety and efficacy of DUAKLIR PRESSAIR in patients with asthma have not been established
• Use of LABA as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

TIOTROPIUM BROMIDE AND OLODATEROL

5 WARNINGS AND PRECAUTIONS LABA as monotherapy (without an inhaled corticosteroid) for asthma increases the risk of serious asthma-related events
Excessive use of STIOLTO RESPIMAT, or use in conjunction with other medications containing LABA can result in clinically significant cardiovascular effects and may be fatal
1 Serious Asthma-Related Events – Hospitalizations, Intubations, Death The safety and efficacy of STIOLTO RESPIMAT in patients with asthma have not been established
Use of long-acting beta 2 -adrenergic agonists (LABA) as monotherapy [without inhaled corticosteroids (ICS)] for asthma is associated with an increased risk of asthma-related death

Clinical Trial Data

No head-to-head clinical studies found for ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL.

ACLIDINIUM BROMIDE AND FORMOTEROL FUMARATE vs TIOTROPIUM BROMIDE AND OLODATEROL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.